Acne vulgaris, probiotics and the gut-brain-skin axis - Back to the future?

Gut Pathogens

Volumn 3, Issue 1, 2011, Pages

  Bowe, Whitney P ^a   Logan, Alan C ^b  

^a SUNY Downstate Medical Center   (United States)

^b Integrative Care Centre of Toronto   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 80755167681     PISSN: None     EISSN: 17574749     Source Type: Journal    
DOI: 10.1186/1757-4749-3-1     Document Type: Review

References (134)

1. Acne vulgaris and depression: a retrospective examination. Uhlenhake E, Yentzer BA, Feldman SR, J Cosmet Dermatol 2010 9 59 63 10.1111/j.1473-2165.2010. 00478.x 20367674
2. Not just 'skin deep': psychosocial effects of dermatological-related social anxiety in a sample of acne patients. Loney T, Standage M, Lewis S, J Health Psychol 2008 13 47 54 10.1177/1359105307084311 18086717
3. Psychological sequelae of acne vulgaris: results of a qualitative study. Magin P, Adams J, Heading G, Pond D, Smith W, Can Fam Phys 2006 52 978 9 (Pubitemid 44449094)
4. Acne, anxiety, depression and suicide in teenagers: a cross-sectional survey of New Zealand secondary school students. Purvis D, Robinson E, Merry S, Watson P, J Paediat Child Health 2006 42 793 6 10.1111/j.1440-1754.2006.00979.x (Pubitemid 44690826)
5. Anger and acne: implications for quality of life, patient satisfaction and clinical care. Rapp DA, Brenes GA, Feldman SR, Fleischer AB, Graham GF, Daily M, Rapp SR, Br J Dermatol 2004 151 183 9 10.1111/j.1365-2133.2004.06078.x 15270889 (Pubitemid 39061297)
6. Psychosocial effects of acne. Thomas DR, J Cutan Med Surg 2004 8 Suppl. 4 3 5 15778823 (Pubitemid 40898113)
7. The quality of life in acne: a comparison with general medical conditions using generic questionnaires. Mallon E, Newton JN, Klassen A, Stewart-Brown SL, Ryan TJ, Finlay AY, Br J Dermatol 1999 140 672 6 10.1046/j.1365-2133.1999. 02768.x 10233319 (Pubitemid 29191387)
8. Risk factors for sebaceous gland diseases and their relationship to gastrointestinal dysfunction in Han adolescents. Zhang H, Liao W, Chao W, Chen Q, Zeng H, Wu C, et al. J Dermatol 2008 35 555 61 10.1111/j.1346-8138.2008. 00523.x 18837699
9. The effect on the skin of emotional and nervous states: theoretical and practical consideration of a gastrointestinal mechanism. Stokes JH, Pillsbury DH, Arch Dermatol Syphilol 1930 22 962 93
10. Lactic acid bacteria in the treatment of melancholia. Norman HJ, Br Med J 1909 1 1234 5
11. The treatment of melancholia by the lactic acid bacillus. Phillips JGP, J Mental Sci 1910 56 422 31
12. A special method of investigating the streptococcal and acidophilus intestinal flora: with results in fifty-three mental patients. Shera G, J Mental Sci 1930 76 56 65
13. Increased incidence of small intestinal bacterial overgrowth during proton pump inhibitor therapy. Lombardo L, Foti M, Ruggia O, Chiecchio A, Clin Gastroenterol Hepatol 2010 8 504 8 10.1016/j.cgh.2009.12.022 20060064
14. Small intestinal bacterial overgrowth syndrome. Bures J, Cyrany J, Kohoutova D, Förstl M, Rejchrt S, Kvetina J, et al. World J Gastroenterol 2010 16 2978 90 10.3748/wjg.v16.i24.2978 20572300
15. Altered intestinal permeability in patients with primary fibromyalgia and in patients with complex regional pain syndrome. Goebel A, Buhner S, Schedel R, Lochs H, Sprotte G, Rheumatology 2008 47 1223 7 10.1093/rheumatology/ken140 18540025 (Pubitemid 352038231)
16. Bacterial overgrowth of the gastrointestinal tract. Toskes PP, Adv Intern Med 1993 38 387 407 8438647
17. Small intestinal bacterial overgrowth and intestinal permeability. Lauritano EC, Valenza V, Sparano L, Scarpellini E, Gabrielli M, Cazzato A, et al. Scand J Gastroenterol 2010 45 1131 2 10.3109/00365521.2010.485325 20443749
18. Effects of psychological stress on small intestinal motility and bacteria and mucosa in mice. Wang SX, Wu WC, World J Gastroenerol 2005 11 2016 21
19. State and trait anxiety and depression in patients affected by gastrointestinal diseases: psychometric evaluation of 1641 patients referred to an internal medicine outpatient setting. Addolorato G, Mirijello A, D'Angelo C, Leggio L, Ferrulli A, Abenavoli L, et al. Int J Clin Pract 2008 62 1063 9 10.1111/j.1742-1241.2008.01763.x 18422970 (Pubitemid 351793590)
20. Eradication of small intestinal bacterial overgrowth decreases symptoms in chronic fatigue syndrome: a double blind, randomized study. Pimentel M, Hallegua D, Chow EJ, Wallace D, Bonorris G, Lin HC, Gastroenterology 2000 118 414 10.1016/S0016-5085(00)83765-8
21. Small intestinal bacterial overgrowth in rosacea: clinical effectiveness of its eradication. Parodi A, Paolino S, Greco A, Drago F, Mansi C, Rebora A, et al. Clin Gastroenterol Hepatol 2008 6 759 64 10.1016/j.cgh.2008.02.054 18456568
22. Probiotic effects on intestinal fermentation patterns in patients with irritable bowel syndrome. Barrett JS, Canale KE, Gearry RB, Irving PM, Gibson PR, World J Gastroenterol 2008 14 5020 4 10.3748/wjg.14.5020 18763284
23. Effects of omega-3 fatty acid deficiency on rat intestinal structure and microbiology. Ralph HJ, Volker DH, Chin J, Asia Pac J Clin Nutr 2004 13 Suppl 79
24. Omega-3 fatty acids in major depressive disorder. Freeman MP, J Clin Psychiatry 2009 70 Suppl 7 11 10.4088/JCP.8157su1c.02 19909687
25. Acne vulgaris, mental health and omega-3 fatty acids: a report of cases. Rubin MG, Kim K, Logan AC, Lipids Health Dis 2008 7 36 10.1186/1476-511X-7-36 18851733
26. Complement fixation in acne vulgaris. Strickler A, Kolmer JA, Schamberg JF, J Cutaneous Dis 1916 34 166 78
27. Fibrin microclot formation in patients with acne. Juhlin L, Michalsson G, Acta Derm Venereol 1983 63 538 40 6198846 (Pubitemid 14208370)
28. Kinin B1 receptors mediate depression-like behavior response in stressed mice treated with systemic E. coli lipopolysaccharide. Viana AF, Maciel IS, Dornelles FN, Figueiredo CP, Siqueira JM, Campos MM, et al. Neuroinflammation 2010 7 98 10.1186/1742-2094-7-98
29. Immune activation in patients with irritable bowel syndrome. Liebregts T, Adam B, Bredack C, Röth A, Heinzel S, Lester S, et al. Gastroenterology 2007 132 913 20 10.1053/j.gastro.2007.01.046 17383420 (Pubitemid 46440872)
30. Acne. Gibbes H, Med Council 1912 17 301 3
31. An address on acne vulgaris. Cleveland DEH, Can Med Assoc J 1928 18 261 66 20316735
32. Gastrointestinal findings in acne vulgaris. Ketron LW, King JH, JAMA 1916 60 671 75
33. Alterations in the colonic flora and intestinal permeability and evidence of immune activation in chronic constipation. Khalif IL, Quigley EM, Konovitch EA, Maximova ID, Dig Liver Dis 2005 7 838 49 10.1016/j.dld.2005.06.008 (Pubitemid 44356113)
34. Methanogenic flora is associated with altered colonic transit but not stool characteristics in constipation without IBS. Attaluri A, Jackson M, Valestin J, Rao SS, Am J Gastroenterol 2010 105 1407 11 10.1038/ajg.2009.655 19953090
35. The gut-brain barrier in major depression: intestinal mucosal dysfunction with an increased translocation of LPS from gram negative enterobacteria (leaky gut) plays a role in the inflammatory pathophysiology of depression. Maes M, Kubera M, Leunis JC, Neuro Endocrinol Lett 2008 29 117 24 18283240
36. Gastrointestinal complaints among subjects with depressive symptoms in the general population. Hillilä MT, Hämäläinen J, Heikkinen ME, Färkkilä MA, Aliment Pharmacol Ther 2008 28 648 54 18564324
37. Intestinal transit in anxiety and depression. Gorard DA, Gomborone JE, Libby GW, Farthing MJ, Gut 1996 39 551 5 10.1136/gut.39.4.551 8944564 (Pubitemid 26376038)
38. Major depressive disorder: probiotics may be an adjuvant therapy. Logan AC, Katzman M, Med Hypotheses 2005 64 533 8 10.1016/j.mehy.2004.08.019 15617861 (Pubitemid 40023014)
39. Chronic fatigue syndrome: lactic acid bacteria may be of therapeutic value. Logan AC, Venket Rao A, Irani D, Med Hypotheses 2003 60 915 23 10.1016/S0306-9877(03)00096-3 12699726 (Pubitemid 36520746)
40. Investigating the role of perceived stress on bacterial flora activity and salivary cortisol secretion: a possible mechanism underlying susceptibility to illness. Knowles SR, Nelson EA, Palombo EA, Biol Psychol 2008 77 132 7 10.1016/j.biopsycho.2007.09.010 18023961
41. Comparative studies of the enteric bacterial flora in acne vulgaris. Loveman DE, Noojin RO, Winkler CH Jr, J Invest Dermatol 1955 25 135 7 13263687
42. Human fecal flora: variation in bacterial composition within individuals and a possible effect of emotional stress. Holdeman LV, Good IJ, Moore WE, Appl Environ Microbiol 1976 31 359 75 938032
43. Impact of the impaired intestinal microflora on the course of acne vulgaris. Volkova LA, Khalif IL, Kabanova IN, Klin Med (Mosk) 2001 79 39 41 Russian 11525176
44. Quantitative studies on normal flora of seborrhoeic dermatitis. Zhang H, Yu L, Yi M, Li K, Chin J Dermatol 1999 32 399 400 Chinese
45. Facts, fads and fancies in the treatment of acne vulgaris. Ereaux LP, Can Med Assoc J 1938 39 257 61 20321089
46. Lactobacillus for the control of acne. Siver RH, J Med Soc New Jersey 1961 59 52 53
47. Efficacy of regulators of the intestinal bacterial flora in the therapy of acne vulgaris. Marchetti F, Capizzi R, Tulli A, Clin Ter 1987 122 339 43 Italian 2972450 (Pubitemid 18068439)
48. Dietary effect of lactoferrin-enriched fermented milk on skin surface lipid and clinical improvement of acne vulgaris. Kim J, Ko Y, Park YK, Kim NI, Ha WK, Cho Y, Nutrition 2010 26 902 9 10.1016/j.nut.2010.05.011 20692602
49. Effect of Lactobacillus plantarum 299v on cardiovascular disease risk factors in smokers. Naruszewicz M, Johansson ML, Zapolska-Downar D, Bukowska H, Am J Clin Nutr 2002 76 1249 55 12450890 (Pubitemid 35416559)
50. Systemic inflammatory markers in older persons: the effect of oral nutritional supplementation with prebiotics. Schiffrin EJ, Thomas DR, Kumar VB, Brown C, Hager C, Van't Hof MA, et al. J Nutr Health Aging 2007 11 475 9 17985062 (Pubitemid 350247017)
51. Lactobacillus fermentum ME-3-an antimicrobial and antioxidative probiotic. Mikelsaar M, Zilmer M, Microb Ecol Health Dis 2009 21 1 27 10.1080/08910600902815561 19381356
52. Clinical implications of lipid peroxidation in acne: old wine in new bottles. Bowe WP, Logan AC, Lipids Health Dis 2010 9 141 10.1186/1476-511X-9-141 21143923
53. Effects of Bifidobacterium bifidum on adaptive immune senescence in aging mice. Fu YR, Yi ZJ, Pei JL, Guan S, Microbiol Immunol 2010 54 578 83 21118295
54. Oral probiotic control skin inflammation by acting on both effector and regulatory T cells. Hacini-Rachinel F, Gheit H, Le Luduec JB, Dif F, Nancey S, Kaiserlian D, PLoS One 2009 4 4903 10.1371/journal.pone.0004903 19300508
55. Immunomodulatory impact of a synbiotic in T(h)1 and T(h)2 models of infection. Cazzola M, Tompkins TA, Matera MG, Ther Adv Respir Dis 2010 4 259 70 10.1177/1753465810379009 20929951
56. Ingested probiotics reduce nasal colonization with pathogenic bacteria (Staphylococcus aureus Streptococcus pneumoniae, and beta-hemolytic streptococci). Glück U, Gebbers JO, Am J Clin Nutr 2003 77 517 20 12540416 (Pubitemid 36133398)
57. Topical bacteriotherapy of the skin. Peyri J, J Cutaneous Dis 1912 30 688 89
58. Effect of the lactic acid bacterium Streptococcus thermophilus on ceramide levels in human keratinocytes in vitro and stratum corneum in vivo. Di Marzio L, Cinque B, De Simone C, Cifone MG, J Invest Dermatol 1999 113 98 106 10.1046/j.1523-1747.1999.00633.x 10417626 (Pubitemid 29328166)
59. Effect of the lactic acid bacterium Streptococcus thermophilus on stratum corneum ceramide levels and signs and symptoms of atopic dermatitis patients. Di Marzio L, Centi C, Cinque B, Masci S, Giuliani M, Arcieri A, et al. Exp Dermatol 2003 12 615 20 10.1034/j.1600-0625.2003.00051.x 14705802 (Pubitemid 37270723)
60. Increase of skin-ceramide levels in aged subjects following a short-term topical application of bacterial sphingomyelinase from Streptococcus thermophilus. Di Marzio L, Cinque B, Cupelli F, De Simone C, Cifone MG, Giuliani M, Int J Immunopathol Pharmacol 2008 21 137 43 18336739 (Pubitemid 351501009)
61. Anti-microbial and -inflammatory activity and efficacy of phytosphingosine: an in vitro and in vivo study addressing acne vulgaris. Pavicic T, Wollenweber U, Farwick M, Korting HC, Int J Cosmet Sci 2007 29 181 90 10.1111/j.1467-2494.2007.00378.x 18489348 (Pubitemid 47024255)
62. Impaired water barrier function in acne vulgaris. Yamamoto A, Takenouchi K, Ito M, Arch Dermatol Res 1995 287 214 8 10.1007/BF01262335 7763094
63. Seasonal variation of dermatologic disease in the USA: a study of office visits from 1990 to 1998. Hancox JG, Sheridan SC, Feldman SR, Fleischer AB Jr, Int J Dermatol 2004 43 6 11 10.1111/j.1365-4632.2004.01828.x 14693014 (Pubitemid 38180578)
64. Lactobacillus paracasei CNCM I-2116 (ST11) inhibits substance P-induced skin inflammation and accelerates skin barrier function recovery in vitro. Gueniche A, Benyacoub J, Philippe D, Bastien P, Kusy N, Breton L, et al. Eur J Dermatol 2010 20 731 7 20965806
65. Bifidobacterium longum lysate, a new ingredient for reactive skin. Guéniche A, Bastien P, Ovigne JM, Kermici M, Courchay G, Chevalier V, et al. Exp Dermatol 2010 19 1 8 19624730
66. Influence of substance-P on cultured sebocytes. Lee WJ, Jung HD, Lee HJ, Kim BS, Lee SJ, Kim do W, Arch Dermatol Res 2008 300 311 6 10.1007/s00403-008- 0854-1 18427822
67. Effect of konjac glucomannan hydrolysates and probiotics on the growth of the skin bacterium Propionibacterium acnes in vitro. Al-Ghazzewi FH, Tester RF, Int J Cosmet Sci 2010 32 139 42 10.1111/j.1468-2494.2009.00555.x 19818083
68. Antimicrobial activity of enterocins from Enterococcus faecalis SL-5 against Propionibacterium acnes, the causative agent in acne vulgaris, and its therapeutic effect. Kang BS, Seo JG, Lee GS, Kim JH, Kim SY, Han YW, et al. J Microbiol 2009 47 101 9 10.1007/s12275-008-0179-y 19229497
69. Inhibition of propionibacterium acnes by bacteriocin-like inhibitory substances (BLIS) produced by Streptococcus salivarius. Bowe WP, Filip JC, DiRienzo JM, Volgina A, Margolis DJ, J Drugs Dermatol 2006 5 868 70 17039652
70. The commensal Streptococcus salivarius K12 downregulates the innate immune responses of human epithelial cells and promotes host-microbe homeostasis. Cosseau C, Devine DA, Dullaghan E, Gardy JL, Chikatamarla A, Gellatly S, et al. Infect Immun 2008 76 4163 75 10.1128/IAI.00188-08 18625732
71. Bacterial interference. Brook I, Crit Rev Microbiol 1999 25 155 72 10.1080/10408419991299211 10524328 (Pubitemid 29471509)
72. The bacillus acidophilus treatment. Saunders AM, Institution Q 1924 15 85 8
73. The use of baker's yeast in diseases of the skin and of the gastrointestinal tract. Hawk PB, Knowles FC, Rehfuss ME, Clarke JA, JAMA 1917 69 1243 47
74. Saccharomyces cerevisiae strain UFMG 905 protects against bacterial translocation, preserves gut barrier integrity and stimulates the immune system in a murine intestinal obstruction model. Generoso SV, Viana M, Santos R, Martins FS, Machado JA, Arantes RM, et al. Arch Microbiol 2010 192 477 84 10.1007/s00203-010-0574-8 20437166
75. The probiotic Bifidobacteria infantis: An assessment of potential antidepressant properties in the rat. Desbonnet L, Garrett L, Clarke G, Bienenstock J, Dinan TG, J Psychiatr Res 2008 43 164 74 10.1016/j.jpsychires. 2008.03.009 18456279
76. Lactobacillus helveticus and Bifidobacterium longum taken in combination reduce the apoptosis propensity in the limbic system after myocardial infarction in a rat model. Girard SA, Bah TM, Kaloustian S, Lada-Moldovan L, Rondeau I, Tompkins TA, et al. Br J Nutr 2009 102 1420 5 10.1017/S0007114509990766 19563693
77. Impact of administered bifidobacterium on murine host fatty acid composition. Wall R, Ross RP, Shanahan F, O'Mahony L, Kiely B, Quigley E, et al. Lipids 2010 45 429 36 10.1007/s11745-010-3410-7 20405232
78. Consumption of functional fermented milk containing borage oil, green tea and vitamin E enhances skin barrier function. Puch F, Samson-Villeger S, Guyonnet D, Blachon JL, Rawlings AV, Lassel T, Exp Dermatol 2008 17 668 74 10.1111/j.1600-0625.2007.00688.x 18318715 (Pubitemid 352044359)
79. Postnatal microbial colonization programs the hypothalamic-pituitary- adrenal system for stress response in mice. Sudo N, Chida Y, Aiba Y, Sonoda J, Oyama N, Yu XN, et al. J Physiol 2004 558 263 75 10.1113/jphysiol.2004.063388 15133062 (Pubitemid 39077406)
80. Chronic gastrointestinal inflammation induces anxiety-like behavior and alters central nervous system biochemistry in mice. Bercik P, Verdu EF, Foster JA, Macri J, Potter M, Huang X, et al. Gastroenterology 2010 139 2102 2112.e1 10.1053/j.gastro.2010.06.063 20600016
81. In vitro and in vivo antioxidant activity of Bifidobacterium animalis 01 isolated from centenarians. Shen Q, Shang N, Pinglan L, Curr Microbiol 2010
82. Memory and learning behavior in mice is temporally associated with diet-induced alterations in gut bacteria. Li W, Dowd SE, Scurlock B, Acosta-Martinez V, Lyte M, Physiol Behav 2009 96 557 67 10.1016/j.physbeh.2008. 12.004 19135464
83. Effects of the probiotic Bifidobacterium infantis in the maternal separation model of depression. Desbonnet L, Garrett L, Clarke G, Kiely B, Cryan JF, Dinan TG, Neuroscience 2010 170 1179 88 10.1016/j.neuroscience.2010.08.005 20696216
84. Specific probiotic therapy attenuates antibiotic induced visceral hypersensitivity in mice. Verdú EF, Bercik P, Verma-Gandhu M, Huang XX, Blennerhassett P, Jackson W, et al. Gut 2006 55 182 90 16105890 (Pubitemid 43117275)
85. The role of pathogenic microbes and commensal bacteria in irritable bowel syndrome. Collins S, Verdu E, Denou E, Bercik P, Dig Dis 2009 27 Suppl 1 85 9 10.1159/000268126 20203502
86. Effects of substance P on memory and mood in healthy male subjects. Herpfer I, Katzev M, Feige B, Fiebich BL, Voderholzer U, Lieb K, Hum Psychopharmacol 2007 22 567 73 10.1002/hup.876 17768771
87. Serum levels of substance P and response to antidepressant pharmacotherapy. Lieb K, Walden J, Grunze H, Fiebich BL, Berger M, Normann C, Pharmacopsychiatry 2004 37 238 9 10.1055/s-2004-832599 15470802 (Pubitemid 39286928)
88. Linkage of the brain-skin-gut axis: islet cells originate from dopaminergic precursors. Teitelman G, Joh TH, Reis DJ, Peptides 1981 2 Suppl 2 157 68 10.1016/0196-9781(81)90026-7 6123986 (Pubitemid 12118298)
89. Diet and acne. Bowe WP, Joshi SS, Shalita AR, J Am Acad Dermatol 2010 63 124 41 10.1016/j.jaad.2009.07.043 20338665
90. A low-glycemic-load diet improves symptoms in acne vulgaris patients: a randomized controlled trial. Smith RN, Mann NJ, Braue A, Mäkeläinen H, Varigos GA, Am J Clin Nutr 2007 86 107 15 17616769 (Pubitemid 47041599)
91. Acne improves with a popular, low glycemic diet from South Beach. Rouhani P, Berman B, Rouhani G, J Am Acad Dermatol 2009 60 suppl 706
92. Depression and insulin resistance: cross-sectional associations in young adults. Pearson S, Schmidt M, Patton G, Dwyer T, Blizzard L, Otahal P, Venn A, Diabetes Care 2010 33 1128 33 10.2337/dc09-1940 20185745
93. Insulin resistance and depressive symptoms in young adult males: findings from Finnish military conscripts. Timonen M, Salmenkaita I, Jokelainen J, Laakso M, Härkönen P, Koskela P, Meyer-Rochow VB, Peitso A, Keinänen-Kiukaanniemi S, Psychosom Med 2007 69 723 8 10.1097/PSY. 0b013e318157ad2e 17942838 (Pubitemid 350287478)
94. Probiotic and gut lactobacilli and bifidobacteria: molecular approaches to study diversity and activity. Kleerebezem M, Vaughan EE, Annu Rev Microbiol 2009 63 269 90 10.1146/annurev.micro.091208.073341 19575569
95. Intestinal microflora, inflammation, and metabolic diseases. Burcelin R, Abstract 019, Keystone Symposia-Diabetes Whistler, British Columbia, Canada 2010
96. Interplay between obesity and associated metabolic disorders: new insights into the gut microbiota. Cani PD, Delzenne NM, Curr Opinion Pharmacol 2009 9 737 43 10.1016/j.coph.2009.06.016
97. Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Cani PD, Possemiers S, Van de Wiele T, Guiot Y, Everard A, Rottier O, et al. Gut 2009 58 1091 103 10.1136/gut.2008.165886 19240062
98. Probiotic yogurt in the elderly with intestinal bacterial overgrowth: endotoxaemia and innate immune functions. Schiffrin EJ, Parlesak A, Bode C, Bode JC, van't Hof MA, Grathwohl D, et al. Br J Nutr 2009 101 961 6 10.1017/S0007114508055591 19353762
99. The epidemiology of adolescent acne in North East China. Wei B, Pang Y, Zhu H, Qu L, Xiao T, Wei HC, Chen HD, He CD, J Eur Acad Dermatol Venereol 2010 24 953 7 10.1111/j.1468-3083.2010.03590.x 20337811
100. The influence of dietary patterns on acne vulgaris in Koreans. Jung JY, Yoon MY, Min SU, Hong JS, Choi YS, Suh DH, Eur J Dermatol 2010 20822969
101. Prevalence, severity, and severity risk factors of acne in high school pupils: a community-based study. Ghodsi SZ, Orawa H, Zouboulis CC, J Invest Dermatol 2009 129 2136 41 10.1038/jid.2009.47 19282841
102. Longitudinal study on pubertal insulin resistance. Goran ML, Gower BA, Diabetes 2001 50 2444 50 10.2337/diabetes.50.11.2444 11679420 (Pubitemid 33642760)
103. Milk consumption and acne in teenaged boys. Adebamowo CA, Spiegelman D, Berkey CS, Danby FW, Rockett HH, Colditz GA, et al. J Am Acad Dermatol 2008 58 787 93 10.1016/j.jaad.2007.08.049 18194824
104. Milk consumption and acne in adolescent girls. Adebamowo CA, Spiegelman D, Berkey CS, Danby FW, Rockett HH, Colditz GA, et al. Dermatol Online J 2006 12 1 17083856
105. High school dietary dairy intake and teenage acne. Adebamowo CA, Spiegelman D, Danby FW, Frazier AL, Willett WC, Holmes MD, J Am Acad Dermatol 2005 52 207 14 10.1016/j.jaad.2004.08.007 15692464
106. Role of insulin, insulin-like growth factor-1, hyperglycaemic food and milk consumption in the pathogenesis of acne vulgaris. Melnik BC, Schmitz G, Exp Dermatol 2009 18 833 41 10.1111/j.1600-0625.2009.00924.x 19709092
107. J Eur Acad Dermatol Venereol. Ben-Amitai D, Laron Z, 2010
108. Colonic absorption of insulin-like growth factor I in vitro. Quadros E, Landzert NM, LeRoy S, Gasparini F, Worosila G, Pharm Res 1994 11 226 30 10.1023/A:1018999106684 8165180 (Pubitemid 24076216)
109. The effects of dairy processes and storage on insulin-like growth factor-I (IGF-I) content in milk and in model IGF-I-fortified dairy products. Kang SH, Kim JU, Imm JY, Oh S, Kim SH, J Dairy Sci 2006 89 402 9 10.3168/jds.S0022-0302(06)72104-X 16428610 (Pubitemid 43226684)
110. Impact of consuming a milk drink containing a probiotic on mood and cognition. Benton D, Williams C, Brown A, Eur J Clin Nutr 2007 61 355 61 10.1038/sj.ejcn.1602546 17151594 (Pubitemid 46358775)
111. A randomized, double-blind, placebo-controlled pilot study of a probiotic in emotional symptoms of chronic fatigue syndrome. Rao AV, Bested AC, Beaulne TM, Katzman MA, Iorio C, Berardi JM, et al. Gut Pathog 2009 1 1 6 10.1186/1757-4749-1-6 19338686
112. Assessment of psychotropic-like properties of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in rats and human subjects. Messaoudi M, Lalonde R, Violle N, Javelot H, Desor D, Nejdi A, et al. Br J Nutr 2010 20974015
113. Clinical trial: the effects of a trans-galactooligosaccharide prebiotic on faecal microbiota and symptoms in irritable bowel syndrome. Silk DB, Davis A, Vulevic J, Tzortzis G, Gibson GR, Aliment Pharmacol Ther 2009 29 508 18 10.1111/j.1365-2036.2008.03911.x 19053980
114. SRL172 (killed Mycobacterium vaccae) in addition to standard chemotherapy improves quality of life without affecting survival, in patients with advanced non-small-cell lung cancer: phase III results. O'Brien ME, Anderson H, Kaukel E, O'Byrne K, Pawlicki M, Von Pawel J, et al. Ann Oncol 2004 15 906 14 15151947 (Pubitemid 39004346)
115. Some psychological aspects of dermatosis. Narciso JC, J Consult Psychol 1952 16 199 201 10.1037/h0057104 14946285
116. Personality and acne. Lucas CJ, Ojha AB, J Psychosom Res 1963 7 41 3 10.1016/0022-3999(63)90050-3 13931398
117. Personality test configurations in acne vulgaris. Wright ET, Kyle NL, Gunter R, Percept Motor Skills 1970 30 191 201 4394479
118. Emotions and acne. Polenghi MM, Zizak S, Molinari E, Dermatol Psychosom 2002 3 20 5 10.1159/000051359 (Pubitemid 34293666)
119. A physician's prospect of the aetiology of acne. Blackburn CRB, Australasian J Dermatol 1951 1 112 17 10.1111/j.1440-0960.1951.tb01411.x
120. Comparison of depression, anxiety and life quality in acne vulgaris patients who were treated with either isotretinoin or topical agents. Kaymak Y, Taner E, Taner Y, Int J Dermatol 2009 48 41 6 10.1111/j.1365-4632.2009.03806.x 19126049
121. Psychosocial impact of acne vulgaris. evaluation of the relation between a change in clinical acne severity and psychosocial state. Mulder MM, Sigurdsson V, van Zuuren EJ, Klaassen EJ, Faber JA, de Wit JB, van Vloten WA, Dermatology 2001 203 124 30 10.1159/000051726 11586010 (Pubitemid 34701571)
122. Prospective study of depressive symptoms and quality of life in acne vulgaris patients treated with isotretinoin compared to antibiotic and topical therapy. Ng CH, Tam MM, Celi E, Tate B, Schweitzer I, Australas J Dermatol 2002 43 262 8 10.1046/j.1440-0960.2002.00612.x 12423432 (Pubitemid 35365415)
123. Cycle control, quality of life and acne with two low-dose oral contraceptives containing 20 microg ethinylestradiol. Winkler UH, Ferguson H, Mulders JA, Contraception 2004 69 469 76 10.1016/j.contraception.2003.12.017 15157791 (Pubitemid 38638747)
124. Depression and suicidal behavior in acne patients treated with isotretinoin: a systematic review. Marqueling AL, Zane LT, Semin Cutan Med Surg 2007 26 210 20 10.1016/j.sder.2008.03.005 18395669 (Pubitemid 351458731)
125. Gut microbiota as a regulator of energy homeostasis and ectopic fat deposition: mechanisms and implications for metabolic disorders. Musso G, Gambino R, Cassader M, Curr Opin Lipidol 2010 21 76 83 10.1097/MOL. 0b013e3283347ebb 19915460
126. Obesity, diabetes, and gut microbiota: the hygiene hypothesis expanded? Musso G, Gambino R, Cassader M, Diabetes Care 2010 33 2277 84 10.2337/dc10-0556 20876708
127. Acne vulgaris: a disease of Western civilization. Cordain L, Lindeberg S, Hurtado M, Hill K, Eaton SB, Brand-Miller J, Arch Dermatol 2002 138 1584 90 10.1001/archderm.138.12.1584 12472346 (Pubitemid 35453471)
128. Comparison of the fecal microflora in rural Japanese and urban Canadians. Benno Y, Suzuki K, Suzuki K, Narisawa K, Bruce WR, Mitsuoka T, Microbiol Immunol 1986 30 521 32 3747865 (Pubitemid 17182951)
129. Effect of rice fiber on human fecal microflora. Benno Y, Endo K, Miyoshi H, Okuda T, Koishi H, Mitsuoka T, Microbiol Immunol 1989 33 435 40 2547140 (Pubitemid 19152051)
130. Comparative effects of very low-carbohydrate, high-fat and high-carbohydrate, low-fat weight-loss diets on bowel habit and faecal short-chain fatty acids and bacterial populations. Brinkworth GD, Noakes M, Clifton PM, Bird AR, Br J Nutr 2009 101 1493 502 10.1017/S0007114508094658 19224658
131. Effect of apple intake on fecal microbiota and metabolites in humans. Shinohara K, Ohashi Y, Kawasumi K, Terada A, Fujisawa T, Anaerobe 2010 16 510 5 10.1016/j.anaerobe.2010.03.005 20304079
132. Subantimicrobial-dose doxycycline in the treatment of moderate facial acne. Toossi P, Farshchian M, Malekzad F, Mohtasham N, Kimyai-Asadi A, Drugs Dermatol 2008 7 1149 52
133. Minocycline in the treatment of acne: latest findings. Maffeis L, Veraldi S, G Ital Dermatol Venereol 2010 145 425 9 20461050
134. Gut microbiota modulation with norfloxacin and ampicillin enhances glucose tolerance in mice. Membrez M, Blancher F, Jaquet M, Bibiloni R, Cani PD, Burcelin RG, et al. FASEB J 2008 22 2416 26 10.1096/fj.07-102723 18326786 (Pubitemid 351948659)